Tuesday, July 18, 2017, 4 p.m. ET: “Cleveland Clinic is deeply committed to caring for Medicaid patients, as it’s a vital part of our mission. Regrettably, we recently received notice from CareSource they may terminate our relationship. It’s important to note, Cleveland Clinic is still under contract through August 31, 2017 and in active discussions with … Read More
News Releases
Cleveland Clinic Names New Chief Information Officer
Cleveland Clinic has appointed Edward Marx as Chief Information Officer (CIO), effective Sept. 1. In this role, he will lead Cleveland Clinic’s information technology (IT) strategy, working with clinical partners and caregivers across the health system to enhance patient care through innovative technologies. Marx brings more than 25 years of experience as a healthcare IT … Read More
Cleveland Clinic Performs Third Face Transplant
In a 31-hour surgery in May, a team of 11 Cleveland Clinic surgeons and multiple specialists performed the hospital’s third face transplant – and its first total face transplant – on a 21-year-old female who suffered severe facial trauma and other complications from a gunshot wound as a teenager. The surgery included transplantation of the … Read More
Cleveland Clinic Names New President of Medina Hospital
MEDINA: Cleveland Clinic today has named Richard Shewbridge, M.D., FACP, as the new President of Cleveland Clinic Medina Hospital, effective July 17. Dr. Shewbridge has served as Vice President of Medical Operations at Medina Hospital since 2011. An endocrinologist, Dr. Shewbridge has been affiliated with Medina since 1996. “Dr. Shewbridge has been a strong … Read More
Bariatric Surgery or Medication/Lifestyle Modifications: Which has Better Long-term Effect on Type 2 Diabetes? Cleveland Clinic-Led Multicenter Trial to Assess Approaches
A team of Cleveland Clinic researchers is leading a first-of-its-kind multicenter clinical trial to assess the long-term outcomes of bariatric/metabolic surgery compared to medical and lifestyle therapy for treating Type 2 diabetes. The Alliance of Randomized Trials of Medicine versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) consortium members are Cleveland Clinic, Joslin Diabetes Center/Brigham … Read More
Cleveland Clinic Researchers Publish New Findings on Influence of High-Fat Diet on Colorectal Cancer
Poor diet is associated with 80 percent of colorectal cancer cases, but the exact pathways by which diet leads to cancer are not known. In a newly published study, Cleveland Clinic researchers have identified a specific molecular pathway that plays a key role in the link between a high-fat diet and tumor growth in the … Read More
Cleveland Clinic Researcher Receives $3.4 M NIH Grant for Epilepsy Surgery Research
The National Institutes of Health (NIH) awarded a $3.4 million grant to Cleveland Clinic to develop a tool to predict individual outcomes in epilepsy surgery. The five-year grant, led by Lara Jehi, M.D., supports the creation of an epilepsy surgery nomogram (ESN) using diagnostic technology and predictive modeling. The project is a five-year collaboration between … Read More
Cleveland Clinic Names Jeffrey Rich, M.D., to Lead Operations, Strategy for Heart & Vascular Institute
Cleveland Clinic has appointed Jeffrey Rich, M.D., as chairman of Operations and Strategy for its Miller Family Heart & Vascular Institute. In this role, Dr. Rich will lead a team from the Heart & Vascular Institute dedicated to managing and growing cardiovascular and cardiac surgery affiliation and alliance relationships across the country. Through these relationships, … Read More
Cleveland Clinic Children’s Ranked Among the Nation’s Best Children’s Hospitals by U.S. News & World Report
Cleveland Clinic Children’s has been ranked as a national leader in clinical care by U.S. News & World Report in its 2017-2018 edition of “Best Children’s Hospitals.” Three of Cleveland Clinic Children’s specialties – cardiology and heart surgery, gastroenterology and GI surgery and Urology – are ranked as the best in Northeast Ohio and among … Read More
Development of New Alzheimer’s Drugs Lagging, Cleveland Clinic Report Finds
LAS VEGAS: Cleveland Clinic’s annual analysis of Alzheimer’s disease drug development highlights an urgent need to increase the number of drugs entering the pipeline and to accelerate the drug testing and approval process. Without changes, the likelihood of reaching the national goal to develop a meaningful therapy by 2025, as established by the Obama … Read More